Drugs / Heat-Labile Enterotoxin of Escherichia coli
Heat-Labile Enterotoxin of Escherichia coli
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00516659 Comparator | May 2006 → Jan 2007 | diarrheal disease | Intercell USA, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Heat-Labile Enterotoxin of Escherichia coli | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00516659 ↗ |
| Modality | Vaccine | “a vaccine containing heat-labile enterotoxin (LT) from ETEC delivered to the skin by patch in travellers to Mexico and Guatemala” PMID 18554712 ↗ Jun 2008 |
| Route | Other | “delivered to the skin by patch” PMID 18554712 ↗ Jun 2008 |